Bone Marrow Transplantation Contents: Volume 57 Number 3

In this Issue: Editorial Perspective Review Article Article Correspondence

Bone Marrow Transplantation Contents: Volume 57 Issue 3

Editorial

Myths in wine and medicine Shaun R. McCann Editorial | 23 November 2021 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01530-4

Relapse of acute leukemia after a second allogeneic stem- cell transplantation; Is there any hope for cure? Avichai Shimoni Editorial | 14 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01508-2

Clinical trials: design, endpoints and interpretation of outcomes Megan Othus, Mei-Jie Zhang & Robert Peter Gale Editorial | 07 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01542-0

Perspective

The first steps towards a diverse and inclusive EBMT: a position paper S. Montoto , J. A. Snowden , C. Chabannon , S. Corbacioglu , R. de la Camara et al. Perspective | 04 February 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-022-01586-w

Review Article

Chimerism analysis for clinicians: a review of the literature and worldwide practices Amanda G. Blouin & Medhat Askar Review Article | 26 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-022-01579-9

Article

Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCT Erik Boberg , Ellen Iacobaeus , Myrto Sklivanioti Greenfield , Yanlu Wang , Mussie Msghina et al. Article | 04 December 2021 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01539-9

Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant Siba El Hussein , Courtney D. DiNardo , Koichi Takahashi , Joseph D. Khoury , Hong Fang et al. Article | 07 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01538-w

Psychosocial outcomes of parents in pediatric haploidentical transplant: parental hematopoietic cell donation as a double-edged sword Vanessa Aguilera , Megan R. Schaefer , Kendra Parris , Alanna Long , Brandon Triplett et al. Article | 10 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01547-9

The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML Avichai Shimoni , Myriam Labopin , Emanuele Angelucci , Didier Blaise , Fabio Ciceri et al. Article | 13 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01493-6

Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin Lina Stutz, Jörg P. Halter, Dominik Heim, Jakob R. Passweg & Michael Medinger Article | 04 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01546-w

Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT Ryszard Swoboda , Myriam Labopin , Sebastian Giebel , Emanuele Angelucci , Mutlu Arat et al. Article | 15 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01550-0

Human leukocyte antigen (HLA) haplotype matching in unrelated single HLA allele mismatch bone marrow transplantation Akihisa Kawajiri , Takakazu Kawase , Hidenori Tanaka , Takahiro Fukuda , Junichi Mukae et al. Article | 21 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01552-y

Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT Juan-Carlos Hernández-Boluda , Arturo Pereira , Nienke Zinger , Luuk Gras , Rodrigo Martino et al. Article | 23 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01553-x

Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients Wolfgang A. Bethge , Matthias Eyrich , Stephan Mielke , Roland Meisel , Dietger Niederwieser et al. Article | 24 December 2021 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01551-z

Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma Raphaël Liévin , Roberta Di Blasi , Florence Morin , Eugenio Galli , Vincent Allain et al. Article | 30 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01526-0

Outcomes after hematopoietic cell transplantation among non-English- compared to English-speaking recipients Ahona Mukherjee , Ted Gooley , Marco Mielcarek , Brenda M. Sandmaier , Kris Doney et al. Article | 31 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01557-7

Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children's Oncology Group experience Jeffrey R. Andolina , Yi-Cheng Wang , Lingyun Ji , David R. Freyer , John E. Levine et al. Article | 06 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01558-6

COVID-19 in HSCT recipients: a collaborative study of the Brazilian Society of Marrow Transplantation (SBTMO) Liane Esteves Daudt , Mariana Cristina Moraes Corso , Mariana Nassif Kerbauy , Luiz Henrique dos Santos de Assis , Ciliana Rechenmacher et al. Article | 13 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01561-x

Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation Johannes Frasez Soerensen , Anni Aggerholm , Carina Agerbo Rosenberg , Marie Bill , Gitte Birk Kerndrup et al. Article | 13 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-022-01567-z

Audit of donor centre: guidelines by the World Marrow Donor Association Quality and Regulation Working Group Maren Weber , Nicoletta Sacchi , Sherry Haun , Ingrid Tistl , Stephanie Thompson et al. Article | 14 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-022-01563-3

Clinical outcomes of individualized busulfan-dosing in hematopoietic stem cell transplantation in Chinese children undergoing with therapeutic drug monitoring Duan-fang Shao , Jun-hui Li , Tao Hu , Zhao-xia Zhang , lei Zhang et al. Article | 17 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01545-x

Disease-specific impact of anti-thymocyte globulin in allogeneic hematopoietic cell transplantation: a nationwide retrospective study on behalf of the JSTCT, transplant complications working group Shigeo Fuji , Tsuneaki Hirakawa , Kuniko Takano , Noriko Doki , Masashi Sawa et al. Article | 17 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-022-01569-x

Ocular graft-versus-host disease and dry eye disease after paediatric haematopoietic stem cell transplantation - incidence and risk factors Helene Jeppesen , Katrine Kielsen , Volkert Siersma , Jens Lindegaard , Hanne Olsen Julian et al. Article | 18 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-022-01564-2

Correspondence

Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT Laure Vincent , Luuk Gras , Patrice Ceballos , Jürgen Finke , Jakob Passweg et al. Correspondence | 10 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01560-y

Chronic graft-versus-host disease exacerbation after SARS-CoV-2 vaccination Andrew D. Trunk, Samuel K. Shewan, Catherine J. Lee, Charles J. Parker & Daniel R. Couriel Correspondence | 11 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-021-01543-z

'Save the day with a Stem Cell Rescue': Use of autologous hematopoietic stem cell boost for hematopoietic recovery after CAR T cell therapy Hamza Hashmi, Abigail Shockley & James A. Davis Correspondence | 17 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-022-01570-4

The impact of blood donation on bone marrow harvest efficiency Iwona Mitrus , Marcin Wilkiewicz , Wojciech Fidyk , Agnieszka Ciomber , Andrzej Smagur et al. Correspondence | 18 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-022-01573-1

Digital-droplet PCR assays for IDH, DNMT3A and driver mutations to monitor after allogeneic stem cell transplantation minimal residual disease of myelofibrosis Daniele Mannina , Anita Badbaran , Christine Wolschke , Evgeny Klyuchnikov , Maximilian Christopeit et al. Correspondence | 19 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-022-01566-0

The role of allogeneic haematopoietic cell transplantation as consolidation after anti-CD19 CAR-T cell therapy in adults with relapsed/refractory acute lymphoblastic leukaemia: a prospective cohort study Shi Han , Lijuan Zhou , Youyou Chen , Xuan Zhou , Zhenling Guo et al. Correspondence | 20 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-022-01572-2

[18F]GE-180 PET/CT assessment of enterocytic translocator protein (TSPO) over-expression: a pilot study in gastrointestinal GVHD Ashleigh P. Scott , Paul Thomas , David A. Pattison , Leo Francis , Paula Ridge et al. Correspondence | 22 January 2022 Bone Marrow Transplantation 57 | doi:10.1038/s41409-022-01571-3

Journal Info Submit Manuscript RSS Feed

This email has been sent to ignoble.experiment@arconati.us by Bone Marrow Transplantation.

Unsubscribe Manage Alerts Privacy policy Contact us

Springer Nature Limited is a company registered in England and Wales under Company Number 785998 with its registered office at The Campus, 4 Crinan Street, London, N1 9XW, United Kingdom

Nature is part of Springer Nature. © 2022 Springer Nature Limited. All rights reserved.